Himalaya Wellness Company

Himalaya Wellness Company, formerly known as The Himalaya Drug Company, was established in 1930 by Mohammad Manal in Dehradun, India. The company is privately held and operates under the parent company, Himalaya Global Holdings Ltd., headquartered in the Cayman Islands. Its global presence includes regional offices in Dubai, Singapore, and Houston, with the main manufacturing facility located in Bangalore, Karnataka, India. As of 2026, Himalaya Wellness Company employs approximately 10,000 individuals worldwide. The company's official website is www.himalayawellness.com.

Himalaya Wellness Company operates a state-of-the-art manufacturing plant in Bangalore, Karnataka, India. This facility specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, adhering to stringent quality standards. The plant's capacity and specific production volumes are not publicly disclosed. The company has also been granted Good Manufacturing Practices (GMP) certification by the Directorate of Indian Systems of Medicine, Bangalore, India, in March 2001, marking it as the first Ayurvedic facility in India to receive such certification.

The leadership team at Himalaya Wellness Company includes:

• Shailendra Malhothra: Global Chief Executive Officer (CEO)

• Jatin Brahmecha: Global Chief Financial Officer (CFO)

These executives play pivotal roles in steering the company's strategic direction and financial management.

Himalaya Wellness Company has established a significant presence in several regulated markets:

• United States: The company entered the U.S. market in 1996, following the introduction of the Dietary Supplement Health and Education Act of 1994.

• European Union (EU): Himalaya's products are available across EU member states, with compliance to EU regulations ensuring market access.

• United Kingdom (UK): The company has a presence in the UK market, offering a range of herbal health and personal care products.

• Australia: Himalaya's products are available in Australia, adhering to the Therapeutic Goods Administration (TGA) regulations.

• Japan: The company has expanded its footprint in Japan, offering products that comply with local health and safety standards.

Himalaya's adherence to regulatory standards in these markets underscores its commitment to quality and consumer safety.

Himalaya Wellness Company has made strategic inroads into emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's commitment to quality and efficacy has facilitated its acceptance in these markets. While specific data on WHO prequalification is not publicly available, Himalaya's adherence to international quality standards positions it favorably for access to these regions.

Himalaya Wellness Company demonstrates a diversified geographic strategy, with a presence in over 100 countries. This global footprint mitigates concentration risk and reflects a strategic direction focused on broad market penetration. The company's expansion into both developed and emerging markets indicates a balanced approach to growth and risk management.

Himalaya Wellness Company has engaged with the U.S. Food and Drug Administration (FDA) to ensure compliance with regulatory standards. Specific details regarding FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. The company's adherence to Good Manufacturing Practices (GMP) and other international standards suggests a commitment to meeting FDA requirements.

Himalaya Wellness Company has been granted Good Manufacturing Practices (GMP) certification by the Directorate of Indian Systems of Medicine, Bangalore, India, in March 2001, marking it as the first Ayurvedic facility in India to receive such certification. While specific details regarding WHO prequalification and EU GMP certificates are not publicly available, the company's adherence to international quality standards positions it favorably in these markets.

Himalaya Wellness Company operates under the regulatory oversight of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Specific details regarding export No Objection Certificates (NOCs) are not publicly disclosed.

As of March 2026, there are no publicly available records of Form 483 observations, warning letters, or import alerts issued to Himalaya Wellness Company by regulatory authorities. The company's adherence to international quality standards and regulatory compliance suggests a proactive approach to maintaining its reputation and operational integrity.

Himalaya Wellness Company operates in a competitive landscape with several key players in the herbal health and personal care sector. While specific market share data is not publicly available, the company's extensive product portfolio and global presence position it as a significant competitor. Himalaya's focus on integrating traditional Ayurvedic knowledge with modern scientific research provides a unique value proposition in the market.

Himalaya Wellness Company's unique strengths include its deep-rooted heritage in Ayurvedic medicine, a comprehensive product portfolio spanning pharmaceuticals, personal care, and animal health, and a commitment to scientific validation of its products. The company's "head-to-heel" wellness solutions and dedication to environmental sustainability further distinguish it in the marketplace.

Himalaya Wellness Company maintains a strategic focus on offering a diverse range of products, including generics, specialty formulations, and personal care items. The company's future outlook appears geared towards expanding its global footprint, enhancing product innovation, and strengthening its position in both developed and emerging markets.

Himalaya Wellness Company demonstrates a strong track record in pharmaceutical manufacturing, with a consistent export volume of $8.9 million USD across 2,599 shipments from 2022 to 2026. The company's portfolio concentration, with the top five products accounting for 100% of exports, indicates a focused and reliable supply chain. Himalaya's adherence to international quality standards and certifications further underscores its reliability as a supplier.

Importers should verify the following certifications when considering products from Himalaya Wellness Company:

• FDA Registration: Confirm the company's compliance with FDA regulations for the U.S. market.

• WHO-GMP Certification: Ensure adherence to World Health Organization Good Manufacturing Practices.

• EU GMP Certification: Verify compliance with European Union Good Manufacturing Practices.

• ISO Certification: Check for ISO certifications related to quality management systems.

These certifications can typically be verified through the respective regulatory bodies' official websites or by contacting Himalaya Wellness Company directly.

When conducting due diligence on Himalaya Wellness Company, consider the following steps:

• Verify Regulatory Compliance: Confirm certifications such as FDA registration, WHO-GMP, EU GMP, and ISO.

• Assess Financial Stability: Review financial statements and credit reports to evaluate the company's financial health.

• Evaluate Product Quality: Request product samples and conduct quality assessments to ensure they meet your standards.

• Review Supply Chain Practices: Examine the company's sourcing, manufacturing, and distribution processes for reliability and ethical practices.

• Check for Regulatory Actions: Investigate any past or pending regulatory actions, such as warning letters or import alerts.

Red flags to watch for include a lack of transparency in certifications, inconsistent product quality, financial instability, and unresolved regulatory issues. Recommended pre-order checks involve obtaining and verifying all relevant certifications, conducting thorough quality assessments, and ensuring clear communication regarding terms and conditions.